Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Robert T. Brodell MD, FAAD Editor-in-Chief

Jane M. Grant-Kels MD, FAAD Advisory Board

Sarah L. Chamlin MD Advisory Board

See All Experts

featured

Published in Dermatology

Journal Scan / Research · May 27, 2015

Vismodegib Safe and Effective in Advanced Basal Cell Carcinoma

Journal of the American Academy of Dermatology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Scott Fosko MD

Journal of the American Academy of Dermatology

Pivotal ERIVANCE Basal Cell Carcinoma (BCC) Study: 12-Month Update of Efficacy and Safety of Vismodegib in Advanced BCC

J Am Acad Dermatol 2015 Jun 01;72(6)1021-1026.e8, A Sekulic, MR Migden, K Lewis, JD Hainsworth, JA Solomon, S Yoo, ST Arron, PA Friedlander, E Marmur, CM Rudin, AL Chang, L Dirix, J Hou, H Yue, A Hauschild

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Vismodegib Safe and Effective in Advanced Basal Cell Carcinoma

Additional Info

Pivotal ERIVANCE Basal Cell Carcinoma (BCC) Study: 12-Month Update of Efficacy and Safety of Vismodegib in Advanced BCC

Further Reading

Long-Term Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Hidradenitis Suppurativa

Association Between Metformin Use and the Risk of Non-Melanoma Skin Cancer

Allergic Contact Dermatitis Owing to Personal Care Product Use Among Men

Provider-Related Factors Associated With an Increased Likelihood of Performing Benign Skin Biopsies

Effects of Comorbidities on Wound Healing in Patients With Pyoderma Gangrenosum

Non-Steroidal Treatment Approaches for the Management of Patients With Atopic Dermatitis

Prevention of Occupational Contact Dermatitis Among Firefighters

Risk of Disease-Specific Mortality Among Patients With Melanoma In Situ Treated With Mohs Micrographic Surgery vs Wide Local Excision

Refusal of Surgery Among Patients With Cutaneous Melanoma: Clinical Predictors and Effect on Melanoma-Specific Survival Outcomes

Role of Systemic Inflammation as a Mediator of the Association Between Skin Disease Severity and Cardiovascular Disease in Patients With Psoriasis

Allergic Contact Cheilitis/Stomatitis Owing to Beverages and Food

Recently Updated